From Discovery to Clinical Impact: AACR Special Conference Captured the Spectrum of Lymphoma Research
At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed...
At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed...
The June edition of Editors’ Picks from the AACR journals included studies on targeting neural cross-talk to stop glioblastoma...
At the AACR Annual Meeting 2026, a session highlighted progress from four Cancer Grand Challenges teams on the interplay...
The cochairs of the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers—Andrew Futreal, PhD, FAACR,...
Can AI agents do cancer research? Many AI-centric research teams currently believe that with the right training, AI agents...
Chenia Lloyd-Gascho, who was diagnosed with Li-Fraumeni syndrome when he was 8 years old, shared what it is like...
Researchers are building AI agents to assess how patients could respond to therapy and aid doctors in making cancer...
At the AACR Annual Meeting 2026, Lillian Siu shared her research into cancer interception and assembled a panel to...